4//SEC Filing
Sherman Rachel E. 4
Accession 0001209191-21-048226
CIK 0001818331other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 6:42 PM ET
Size
6.4 KB
Accession
0001209191-21-048226
Insider Transaction Report
Form 4
Sherman Rachel E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-22+363,223→ 363,223 totalExercise: $0.77Exp: 2030-02-17→ Class A Common Stock (363,223 underlying)
Footnotes (2)
- [F1]6.25% of the total shares underlying the option vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F2]Pursuant to the business combination between the Issuer (which was formerly known as CM Life Sciences, Inc.) and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), each share of Sema4 outstanding common stock was automatically converted into the right to shares of the Issuer's Class A Common Stock based on a 1 to 123.8338 exchange ratio ("Exchange Ratio"). In addition, each outstanding Sema4 equity award was automatically converted into a corresponding equity award of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Sema4 equity awards.
Documents
Issuer
Sema4 Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001784705
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 6:42 PM ET
- Size
- 6.4 KB